News about Medicine

Change in transfer and breeding instruction forms and reviewing the department’s SOPs

Please read the information here.

Power shutdown at the Biocenter

The power shutdown applies to the entire basement in building 2. It will affect ventilation and other installations in animal facility, including lights (electronic board 2.01.AB). If the shutdown gives rise to…

A more efficient technology for oromucosal drug delivery

The project SAFE Patch recently received 1.5 mill DKK from the Innovation Fund Denmark’s InnoExplorer program to explore and develop the new “SAFE Patch” technology and bring it closer to commercialization.

Construction work near the Biocenter - Test piloting performed

The piloting will begin on Monday Janurary 30th, and it is expected to last approx. 10 working days. AEM is still in dialogue with the contractor, and should you experience any irregularities, you are very welcome to…

Construction work near the Biocenter - Test piloting

As mentioned, the construction work involves driving 32 steel piles into the ground during the month of February. A meeting with the contractor and the Maintenance Department was held yesterday due our concern for the…

Construction work near the Biocenter

There is a risk that this type of construction work may be noisy and can sometimes produce low-frequency vibrations. For further details, please see the attached letter from the construction management (in Danish only).…

Niels Behrendt receives the NNF Distinguished Innovator Grant

Niels Behrendt, group leader at the Finsen Laboratory, Rigshospitalet/BRIC receives the NNF Distinguished Innovator grant for a project focused on creating test ADC therapeutics.

Gene targeting in cell lines

Here we apply apply our expertise in CRISPR/Cas9-mediated genome editing to cell lines. We can now help you generating your new in vitro experimental system by knocking out your gene of interest, or introducing point…

Last chance to register for 12th Uppsala University Pharmaceutical Profiling in Drug Discovery and Development Symposium

The registration for the 12th Uppsala University Pharmaceutical Profiling in Drug Discovery and Development Symposium is closing on Dec 21 and there are still places available. To all Nordic POP members, we also want to…

Newsletter from AEM

Please read the whole newsletter here. Visit by the AAALAC accreditation panel All project plans are valid for two years after which they must be renewed Information from suppliers of animals Price adjustments from…

Scientists remove yeast cell's sex drive and turn it into a cannabis tracker

Researchers at the University of Copenhagen's Faculty of Science have modified a yeast cell to sense the active substances in cannabis and get it to turn red when it does. The result paves the way for more actors to…

Risk and resilience during the COVID-19 pandemic

The study identified five key themes in the experiences of people living with chronic illnesses during the pandemic: wellbeing, normality, healthcare access, coping resources, and meaningfulness.

New gene technology is able to predict the effect of treatment on the individual breast cancer patient

How do you know whether breast cancer treatment will be able to cure the individual patient? New gene technology can tell us, and it may prove vital to patients.

All project plans are valid for two years after which they must be renewed

All project plans beginning with a P- or A-number lower than these will be invalid, which means that you cannot order animals or begin a new experiment. Therefore, if your project plan will or has expired, you need to…

Major discovery about mammalian brains surprises researchers

In a new breakthrough to understand more about the mammalian brain, University of Copenhagen researchers have made an incredible discovery. Namely, a vital enzyme that enables brain signals is switching on and off at…

Seminar on Current Regulatory Actions Addressing Pharmaceuticals in the Environment was held on Nov 3, 2022 in Helsinki

A hybrid seminar on Current Regulatory Actions Addressing Pharmaceuticals in the Environment was hosted by the University of Helsinki on November 3, 2022. The seminar gathered together ca. 40 participants live in…

A new workshop on physiologically based pharmacokinetic modeling well received

A new workshop on physiologically based pharmacokinetic modeling was organised at the University of Eastern Finland recently, with the internationally invited lecturers Professor Leon Aarons from the University of…

Stem cell therapy for Parkinson’s Disease granted approval for entering clinical trial in Sweden

Associate Professor and Principal Investigator from reNEW UCPH brings hope to people with Parkinson’s Disease by being part of a decade long team effort between universities and hospitals in Sweden and the UK.

Excessive brain fluid can lead to risky surgery. New research seeks to change that

Researchers from the University of Copenhagen have discovered that fluid does not necessarily enter the brain the way one thought. According to one of the researchers behind the study, the result may lead to fewer major…

Translational AML trial improves clinical outcome and identifies novel drugs for future treatment

The LD-VenEx trial exemplifies the vast potential of clinical trials integrating translational research programs, says research group leader Kim Theilgaard-Mönch. In a large investigator-initiated trial, clinicians form…

Five SUND-researchers get DKK 42 million to exciting projects

Five researchers from the Faculty of Health and Medical Sciences receive big grants from the Novo Nordisk Foundation.

Major investment for developing Denmark’s first fully functional quantum computer

Denmark’s first fully functional generally applicable quantum computer will be available in 2034. This is the objective of the ambitious Novo Nordisk Foundation Quantum Computing Programme that is being launched in…

Major investment for developing Denmark’s first fully functional quantum computer

Denmark’s first fully functional generally applicable quantum computer will be available in 2034. This is the objective of the ambitious Novo Nordisk Foundation Quantum Computing Programme that is being launched in…

“Extremely satisfying” as researchers find new hope for heart patients

There is currently no cure for the heart condition ARVC, which usually affects young individuals. A new study from the University of Copenhagen presents a surprising new treatment strategy.